Status:
COMPLETED
Exercise on Expression of Heat Shock Protein 70 in Arterial Risk
Lead Sponsor:
Universidad Popular Autónoma del Estado de Puebla
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Introduction: Atherosclerotic Peripheral Arterial Disease (PAD) is the leading cause of mortality in the western world. To maintain homeostasis of the vessel wall, vascular cells produce a high level ...
Detailed Description
The objective of the study is to determine the level of serum expression of the HSP70 protein in individuals at risk of atherosclerotic peripheral arterial disease, after an intervention of moderate e...
Eligibility Criteria
Inclusion
- Individuals who attended the internal medicine service of the "Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado de Puebla" (ISSSTEP) Hospital were invited to participate voluntarily, from February to September of 2019. In order to detect people at risk of PAD, the measurement of the ABI was done. The measure was taken after 10 minutes of resting. The measure was taken in the four extremities to obtain systolic BP of the posterior tibial artery and brachial artery. The cut point to enter the study was between 0.91 and 0.99 mmHg. The informed consent was signed by all the individuals.
- Inclusion criteria
- ABI cut point from 0.91 to 0.99
- Age, from 40 to 75 years old
- Both genders
- Exclusion criteria
- Unable to perform Bruce's stress test
- Presence of fractures or sprains in the last 3 months
- Diagnosis of diabetes, heart disease, angina pectoris or heart attack
Exclusion
Key Trial Info
Start Date :
June 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04743128
Start Date
June 3 2019
End Date
August 30 2019
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPAEP
Puebla City, Mexico, 72410